Fentanyl Vaccine Developed By Researchers Could Eliminate Drug's 'High'

Researchers have developed a fentanyl vaccine that could eliminate the drug's 'high' by blocking its ability to enter the brain -- which could be a major step forward in the ongoing opioid crisis. Yahoo News reports: The study, conducted by a research team led by the University of Houston and funded by the Department of Defense through the Alcohol and Substance Abuse Disorder Research Program, was published in the journal Pharmaceutics at the end of October. Colin Haile, a research associate professor of psychology and lead author of the study, said in a news release that the vaccine 'is able to generate anti-fentanyl antibodies that bind to the consumed fentanyl and prevent it from entering the brain, allowing it to be eliminated out of the body via the kidneys. 'Thus, the individual will not feel the euphoric effects and can 'get back on the wagon' to sobriety.'

Haile added that the anti-fentanyl antibodies didn't cross-react with other opioids, meaning a vaccinated person could still be treated for pain relief with other opioids. The vaccine did not cause any adverse side effects in rats involved in lab studies, and clinical trials in humans are planned 'soon,' with manufacturing of clinical-grade vaccine to begin in the coming months.

Read more of this story at Slashdot.